HIGH-RISK MULTIPLE MYELOMA (MM): DISTINGUISHING EARLY FAILURES (EF) FROM SUSTAINED CONTROL (SC) B. Barlogie, J. D. Shaughnessy Jr, J. Haessler, A. Hoering, F. Van Rhee, E.…

1. Prostate Cancer:Modernising The DiagnosticPathwayMarc Laniado MD FEBU FRCS(Urol)Consultant Urological [email protected]@[email protected]…

1. Breakthroughs in the treatment of acute promyelocytic leukemia: curable disease with retinoic and arsenic Jiong HU Shanghai Institute of Hematology, Department of Hematology,…

1. Pediatr Clin N Am 55 (2008) 97–120Neuroblastoma: Biology, Prognosis,and Treatment Julie R. Park, MDa,*, Angelika Eggert, MDb,Huib Caron, MD, PhDcaDivision of Hematology…

Mayo School of Continuous Professional Development The Westin Kierland Resort Scottsdale, Arizona Friday – Sunday December 7-9, 2012 7th Annual Practical Course in Dermoscopy…

Slide 1 Breakthroughs in the treatment of acute promyelocytic leukemia: curable disease with retinoic and arsenic Jiong HU Shanghai Institute of Hematology, Department of…

Slide 1Long-Term versus Short-Term Androgen Deprivation Combined with High-Dose Radiotherapy for Intermediate and High Risk Prostate Cancer: Preliminary Results of a Phase…

Breakthroughs in the treatment of acute promyelocytic leukemia: curable disease with retinoic and arsenic Jiong HU Shanghai Institute of Hematology, Department of Hematology,…

Breakthroughs in the treatment of acute promyelocytic leukemia: curable disease with retinoic and arsenic Jiong HU Shanghai Institute of Hematology, Department of Hematology,…

Neuroblastoma Rumey C. Ishizawar April 29, 2005 Clinical History CC: Rt leg pain with refusal to bear weight. HPI: a 5 yo male c/o a 4 wk history of Rt flank pain with progression…